CARLY CORREA: Open Payments
NPI 1992206973 · KAMUELA, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$815 in 25 payments from 10 companies in 2025. Trend: 2023 $547 · 2024 $1,042 · 2025 $815
Food & beverage: $815
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $328 |
| Janssen Biotech, Inc. | 2 | $190 |
| PFIZER INC. | 3 | $61 |
| Exact Sciences Corporation | 2 | $61 |
| Vanda Pharmaceuticals Inc. | 2 | $49 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Gilead Sciences, Inc. | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $27 |
| Novo Nordisk Inc | 1 | $24 |
| ABBVIE INC. | 1 | $16 |
Products named: OTEZLA, TREMFYA, EVENITY, FANAPT, PAXLOVID, Cologuard Collection Kit, Auvelity, AIRSUPRA.
Industry payments across HI — which companies pay providers there.
